<?xml version="1.0" encoding="UTF-8" ?><!-- Generated on Fri, 10 Apr 2026 15:52:42 -0400--><rss version="2.0">
    <channel>
        <title>DiaMedica Therapeutics, Inc. (DMAC) Press Releases</title>
        <link>https://www.diamedica.com/investors/press-releases/rss</link>
        <description></description>
        <language>en-us</language>
                                            <image>
                <url>https://d1io3yog0oux5.cloudfront.net/diamedica/files/theme/images/logo-sm.png</url>
                <title>DiaMedica Therapeutics, Inc. Logo</title>
                <link>/investors</link>
            </image>
                <generator>Equisolve Investor Relations Suite</generator>
        
                            <item>
                <title><![CDATA[DiaMedica Therapeutics Reports Full Year 2025 Financial Results and Provides Business Highlights]]></title>
                <description><![CDATA[]]></description>
                <link>https://www.diamedica.com/investors/press-releases/detail/1723/diamedica-therapeutics-reports-full-year-2025-financial</link>
                <pubDate>Mon, 30 Mar 26 16:45:00 -0400</pubDate>
                <guid isPermalink="true">https://www.diamedica.com/investors/press-releases/detail/1723/diamedica-therapeutics-reports-full-year-2025-financial</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[DiaMedica Therapeutics to Report Fourth Quarter 2025 Financial Results and Provide a Business Update March 31, 2026]]></title>
                <description><![CDATA[]]></description>
                <link>https://www.diamedica.com/investors/press-releases/detail/1722/diamedica-therapeutics-to-report-fourth-quarter-2025</link>
                <pubDate>Mon, 23 Mar 26 08:25:00 -0400</pubDate>
                <guid isPermalink="true">https://www.diamedica.com/investors/press-releases/detail/1722/diamedica-therapeutics-to-report-fourth-quarter-2025</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[DiaMedica Therapeutics Receives Health Canada Clearance to Initiate Phase 2 Study of DM199 in Preeclampsia]]></title>
                <description><![CDATA[]]></description>
                <link>https://www.diamedica.com/investors/press-releases/detail/1721/diamedica-therapeutics-receives-health-canada-clearance-to</link>
                <pubDate>Thu, 05 Mar 26 07:35:00 -0500</pubDate>
                <guid isPermalink="true">https://www.diamedica.com/investors/press-releases/detail/1721/diamedica-therapeutics-receives-health-canada-clearance-to</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[DiaMedica Therapeutics to Participate in Upcoming March Investor Conferences]]></title>
                <description><![CDATA[]]></description>
                <link>https://www.diamedica.com/investors/press-releases/detail/1720/diamedica-therapeutics-to-participate-in-upcoming-march</link>
                <pubDate>Tue, 24 Feb 26 09:23:00 -0500</pubDate>
                <guid isPermalink="true">https://www.diamedica.com/investors/press-releases/detail/1720/diamedica-therapeutics-to-participate-in-upcoming-march</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[DiaMedica Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)]]></title>
                <description><![CDATA[]]></description>
                <link>https://www.diamedica.com/investors/press-releases/detail/1719/diamedica-announces-inducement-grants-under-nasdaq-listing</link>
                <pubDate>Fri, 16 Jan 26 17:00:00 -0500</pubDate>
                <guid isPermalink="true">https://www.diamedica.com/investors/press-releases/detail/1719/diamedica-announces-inducement-grants-under-nasdaq-listing</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[DiaMedica Therapeutics Provides DM199 Preeclampsia Program Update Following Pre-IND Meeting with FDA]]></title>
                <description><![CDATA[]]></description>
                <link>https://www.diamedica.com/investors/press-releases/detail/1718/diamedica-therapeutics-provides-dm199-preeclampsia-program</link>
                <pubDate>Thu, 18 Dec 25 08:45:00 -0500</pubDate>
                <guid isPermalink="true">https://www.diamedica.com/investors/press-releases/detail/1718/diamedica-therapeutics-provides-dm199-preeclampsia-program</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[DiaMedica Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Highlights]]></title>
                <description><![CDATA[]]></description>
                <link>https://www.diamedica.com/investors/press-releases/detail/1717/diamedica-therapeutics-reports-third-quarter-2025-financial</link>
                <pubDate>Wed, 12 Nov 25 16:30:00 -0500</pubDate>
                <guid isPermalink="true">https://www.diamedica.com/investors/press-releases/detail/1717/diamedica-therapeutics-reports-third-quarter-2025-financial</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[DiaMedica Therapeutics to Participate in the Jefferies Global Healthcare Conference in London]]></title>
                <description><![CDATA[]]></description>
                <link>https://www.diamedica.com/investors/press-releases/detail/1716/diamedica-therapeutics-to-participate-in-the-jefferies</link>
                <pubDate>Mon, 10 Nov 25 08:15:00 -0500</pubDate>
                <guid isPermalink="true">https://www.diamedica.com/investors/press-releases/detail/1716/diamedica-therapeutics-to-participate-in-the-jefferies</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[DiaMedica Therapeutics to Report Third Quarter 2025 Financial Results and Provide a Business Update November 13, 2025]]></title>
                <description><![CDATA[]]></description>
                <link>https://www.diamedica.com/investors/press-releases/detail/1715/diamedica-therapeutics-to-report-third-quarter-2025</link>
                <pubDate>Thu, 06 Nov 25 16:15:00 -0500</pubDate>
                <guid isPermalink="true">https://www.diamedica.com/investors/press-releases/detail/1715/diamedica-therapeutics-to-report-third-quarter-2025</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[DiaMedica Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)]]></title>
                <description><![CDATA[]]></description>
                <link>https://www.diamedica.com/investors/press-releases/detail/1714/diamedica-announces-inducement-grants-under-nasdaq-listing</link>
                <pubDate>Mon, 29 Sep 25 16:15:00 -0400</pubDate>
                <guid isPermalink="true">https://www.diamedica.com/investors/press-releases/detail/1714/diamedica-announces-inducement-grants-under-nasdaq-listing</guid>
                                                                            </item>
            </channel>
</rss>